Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

How Grim is Pancreatic Cancer?

Weledji EP, Enoworock G, Mokake M, Sinju M.

Oncol Rev. 2016 Jul 6;10(1):294. doi: 10.4081/oncol.2016.294. eCollection 2016 Apr 15. Review.

2.

Dilemmas in the management of screen-detected lesions in patients at high risk for pancreatic cancer.

Ibrahim IS, Bonsing BA, Swijnenburg RJ, Welling L, Veenendaal RA, Wasser MN, Morreau H, Inderson A, Vasen HF.

Fam Cancer. 2017 Jan;16(1):111-115. doi: 10.1007/s10689-016-9915-3.

3.

Genomic instability in pancreatic adenocarcinoma: a new step towards precision medicine and novel therapeutic approaches.

Sahin IH, Lowery MA, Stadler ZK, Salo-Mullen E, Iacobuzio-Donahue CA, Kelsen DP, O'Reilly EM.

Expert Rev Gastroenterol Hepatol. 2016 Aug;10(8):893-905. doi: 10.1586/17474124.2016.1153424. Epub 2016 Feb 26. Review.

PMID:
26881472
4.

Viro-immune therapy: A new strategy for treatment of pancreatic cancer.

Ibrahim AM, Wang YH.

World J Gastroenterol. 2016 Jan 14;22(2):748-63. doi: 10.3748/wjg.v22.i2.748. Review.

5.

Pancreatic Cancer: a Challenge to Cure.

Tewari M.

Indian J Surg. 2015 Oct;77(5):350-7. doi: 10.1007/s12262-015-1369-6. Epub 2015 Oct 19.

6.

Combining in Vitro Diagnostics with in Vivo Imaging for Earlier Detection of Pancreatic Ductal Adenocarcinoma: Challenges and Solutions.

Laeseke PF, Chen R, Jeffrey RB, Brentnall TA, Willmann JK.

Radiology. 2015 Dec;277(3):644-61. doi: 10.1148/radiol.2015141020.

7.

Current status and progress of pancreatic cancer in China.

Lin QJ, Yang F, Jin C, Fu DL.

World J Gastroenterol. 2015 Jul 14;21(26):7988-8003. doi: 10.3748/wjg.v21.i26.7988. Review.

8.

Role of Parathyroid Hormone-Related Protein Signaling in Chronic Pancreatitis.

Falzon M, Bhatia V.

Cancers (Basel). 2015 Jun 18;7(2):1091-108. doi: 10.3390/cancers7020826. Review.

9.

Imaging and Therapy of Pancreatic Cancer with Phosphatidylserine-Targeted Nanovesicles.

Blanco VM, Latif T, Chu Z, Qi X.

Transl Oncol. 2015 Jun;8(3):196-203. doi: 10.1016/j.tranon.2015.03.011. Review.

10.

New targeted therapies in pancreatic cancer.

Seicean A, Petrusel L, Seicean R.

World J Gastroenterol. 2015 May 28;21(20):6127-45. doi: 10.3748/wjg.v21.i20.6127. Review.

11.

Chronic hyperglycemia induces trans-differentiation of human pancreatic stellate cells and enhances the malignant molecular communication with human pancreatic cancer cells.

Kiss K, Baghy K, Spisák S, Szanyi S, Tulassay Z, Zalatnai A, Löhr JM, Jesenofsky R, Kovalszky I, Firneisz G.

PLoS One. 2015 May 26;10(5):e0128059. doi: 10.1371/journal.pone.0128059. eCollection 2015.

12.

A histomorphologic comparison of familial and sporadic pancreatic cancers.

Singhi AD, Ishida H, Ali SZ, Goggins M, Canto M, Wolfgang CL, Meriden Z, Roberts N, Klein AP, Hruban RH.

Pancreatology. 2015 Jul-Aug;15(4):387-91. doi: 10.1016/j.pan.2015.04.003. Epub 2015 Apr 23.

13.

Novel approaches in the management of pancreatic ductal adenocarcinoma: potential promises for the future.

Goel G, Sun W.

J Hematol Oncol. 2015 May 3;8:44. doi: 10.1186/s13045-015-0141-5. Review.

14.

Whipple procedure: a review of a 7-year clinical experience in a referral center for hepatobiliary and pancreas diseases.

Saraee A, Vahedian-Ardakani J, Saraee E, Pakzad R, Wadji MB.

World J Surg Oncol. 2015 Mar 11;13:98. doi: 10.1186/s12957-015-0523-8.

15.

Pancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parameters.

Urayama S.

World J Gastroenterol. 2015 Feb 14;21(6):1707-17. doi: 10.3748/wjg.v21.i6.1707. Review.

16.

Pathology of pancreatic ductal adenocarcinoma: facts, challenges and future developments.

Esposito I, Konukiewitz B, Schlitter AM, Klöppel G.

World J Gastroenterol. 2014 Oct 14;20(38):13833-41. doi: 10.3748/wjg.v20.i38.13833. Review.

17.

Familial and sporadic pancreatic cancer share the same molecular pathogenesis.

Norris AL, Roberts NJ, Jones S, Wheelan SJ, Papadopoulos N, Vogelstein B, Kinzler KW, Hruban RH, Klein AP, Eshleman JR.

Fam Cancer. 2015 Mar;14(1):95-103. doi: 10.1007/s10689-014-9755-y.

18.

Early detection and prevention of pancreatic cancer: is it really possible today?

Del Chiaro M, Segersvärd R, Lohr M, Verbeke C.

World J Gastroenterol. 2014 Sep 14;20(34):12118-31. doi: 10.3748/wjg.v20.i34.12118. Review.

19.

Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection.

Becker AE, Hernandez YG, Frucht H, Lucas AL.

World J Gastroenterol. 2014 Aug 28;20(32):11182-98. doi: 10.3748/wjg.v20.i32.11182. Review.

20.

Therapeutic options for the management of pancreatic cancer.

Rossi ML, Rehman AA, Gondi CS.

World J Gastroenterol. 2014 Aug 28;20(32):11142-59. doi: 10.3748/wjg.v20.i32.11142. Review.

Supplemental Content

Support Center